Search

everythinglearnresearchcommunity

for

Search:↓

Repigmentation patterns in vitiligo depend on melanocyte source, lesion status, and therapy choice.

PmtHEE is a better model for studying pigmented skin because it includes melanocytes and shows improved cell differentiation.

Microdermabrasion combined with Q-switched Nd:YAG laser is a safe and effective way to treat stubborn melasma.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

New microneedles may improve vitiligo treatment.

Removing Dicer from pigment cells in newborn mice causes early hair graying and changes in cell migration molecules.

Melanocytes from human fetal hair follicles were successfully cultured, showing potential for hair disease research and clinical use.

Lophocereus marginatus extracts may help treat melanoma and stimulate hair growth.

Hair dye ingredient PPD causes cell death and aging in human hair cells by altering microRNA levels.

Neuropilin 2 may be a biomarker for melanoma and affects melanocyte behavior.

Antizyme slows skin tumor growth by reducing cell growth in mice.

Enhancing CD8+ T cell function to induce ferroptosis in tumor cells may help treat skin melanoma.

Melanoma survivors are more likely to use sunscreen and seek shade than others, but less than half often use sunscreen and avoid the sun, and some still use tanning beds.

Effective treatments for premature hair graying still require significant research.

TRH in hair follicles can influence hair color by increasing melanin.

Melatonin reduced oxidative damage, inflammation, and protected hair cells in scalded rats.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

The new cream with N-acetyl glucosamine didn't change skin color after 8 weeks.

New vitiligo treatments focus on controlling immune damage and restoring skin color.

Melanoma research shifted focus to immunotherapy drugs after 2010, increasing their study and citations.

FilaggrinHigh melanomas have active FGFR signaling and weak GNA14 and Th1 signatures.

Most patients' skin darkening after sclerotherapy fades on its own within 6-24 months.

Melanocytes in the outer root sheath are likely stem cells that grow fast but stay immature.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Overexpression of HDGF in melanocytes does not cause cancer.

Pigmented rings with central clearing help diagnose melasma more accurately.

The Wnt/β-catenin pathway can activate melanocyte stem cells and may help regenerate hair follicles.

Langerhans' cells are not involved in hair depigmentation in these mice.